# Eltrombopag for Inherited Thrombocytopenias

> **NCT02422394** · PHASE2 · COMPLETED · sponsor: **Fondazione IRCCS Policlinico San Matteo di Pavia** · enrollment: 24 (actual)

## Conditions studied

- Inherited Platelet Disorder

## Interventions

- **DRUG:** Eltrombopag

## Key facts

- **NCT ID:** NCT02422394
- **Lead sponsor:** Fondazione IRCCS Policlinico San Matteo di Pavia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2018-03
- **Final completion:** 2018-03
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02422394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02422394, "Eltrombopag for Inherited Thrombocytopenias". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02422394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*